| Literature DB >> 12192549 |
Michele Klain1, Marcel Ricard, Sophie Leboulleux, Eric Baudin, Martin Schlumberger.
Abstract
Radioiodine ((131)I) therapy is used in patients with papillary and follicular thyroid carcinoma for ablation of thyroid remnants and for treatment of persistent or recurrent disease. It should be used selectively, i.e. only in those patients for whom a clinical benefit may be expected.Entities:
Mesh：
Substances：
Year: 2002 PMID： 12192549 DOI： 10.1007/s00259-002-0810-9
Source DB: PubMed Journal: Eur J Nucl Med Mol Imaging ISSN： 1619-7070 Impact factor: 9.236